Medications of interest included angiotensin converting enzyme inhibitors (ACEi), angiotensin II receptor blockers (ARB), aldosterone antagonists, β-blockers, calcium-channel blockers, loop diuretics and thiazide diuretics. Patients taking prescription medications containing one or more drug classes were ...
4.4% of episodes were linked to treatment with non-steroidal anti-inflammatory drugs (NSAID), 7.7% to blockade of the renin-angiotensin-aldosterone-system (RAAS) with angiotensin-converting enzyme inhibitors (ACEI), angiotensin receptor blockers or spironolactone and 3.3% to the use of thiazide or...